|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.33/-0.54
|
企业价值
174.91M
|
资产负债 |
每股账面净值
0.46
|
现金流量 |
现金流量率
--
|
损益表 |
收益
6.51M
|
每股收益
0.06
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/18 20:20 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. |